The false negative rates do not appear out of line with the test's sensitivity figures, but issues have been raised with its workflow and the firm's marketing strategy.

As we move towards more personalized medicine, the importance of precision diagnostics is increasing. Yet, most molecular diagnostics testing remains complex, inefficient, and out of reach for many ...